Evidence map›Paper›PMID 42375128›Full record

ReviewChembiochem : a European journal of chemical biology2026

Oligonucleotides Post-Synthetic Modifications: An Overview of Clickable Nucleoside Phosphoramidites Suitable for Solid-Phase Synthesis.

Sébastien Depienne, Alexandra Bristiel, Dominique Urban, Dominique Guianvarc'h

Abstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sébastien DepienneUniversité Paris-Saclay, CNRS, Institut de Chimie Moléculaire et des Matériaux d'Orsay, UMR CNRS 8182, Orsay, France.ORCID 0000-0003-1124-2892
Alexandra BristielUnité Drug Design Small Molecules, Institut de Recherche et Développement Servier Paris-Saclay, Gif-sur-Yvette, France.
Dominique UrbanUniversité Paris-Saclay, CNRS, Institut de Chimie Moléculaire et des Matériaux d'Orsay, UMR CNRS 8182, Orsay, France.
Dominique Guianvarc'hUniversité Paris-Saclay, CNRS, Institut de Chimie Moléculaire et des Matériaux d'Orsay, UMR CNRS 8182, Orsay, France.ORCID 0000-0002-7722-370X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical modification of oligonucleotides has become an essential strategy to improve their properties and expand their functional utility in chemical biology, molecular imaging, and therapeutics. Among the various modification strategies, post-synthetic bioorthogonal click chemistry enables efficient, rapid, and biocompatible site-specific conjugation of functional moieties. Central to these advances is the development of clickable nucleoside phosphoramidites, namely nucleoside building blocks containing reactive bioorthogonal click handles that are compatible with the harsh conditions of solid-phase oligonucleotide synthesis (SPOS). This review provides a comprehensive overview of bioorthogonal cycloaddition-based nucleoside phosphoramidites reported to date that are compatible with SPOS. We highlight their synthetic accessibility and deviations from conventional SPOS protocols when required, as well as the stability and hybridization behavior of the resulting clickable oligonucleotides. Furthermore, we examine the performance of subsequent bioorthogonal reactions used for post-synthetic functionalization, with particular attention to their kinetics and efficiencies. Representative applications are also discussed, including the development of labeled probes, multifunctional assemblies, and targeted delivery systems.

Indexed as

Click ChemistryNucleosidesOligonucleotidesOrganophosphorus CompoundsSolid-Phase Synthesis TechniquesCycloaddition ReactionNucleosidesOligonucleotidesOrganophosphorus Compoundsphosphoramiditebioorthogonal chemistryclick chemistryoligonucleotidespost‐synthetic modificationsolid‐phase oligonucleotides synthesis

Identifiers

PMID42375128
PMCPMC13316733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.